Production (Stage)
OnKure Therapeutics, Inc.
OKUR
$2.88
$0.020.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 96.66M | 110.76M | 18.63M | 19.25M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 1.51M | 2.24M | 5.16M | 3.46M | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 98.17M | 113.00M | 23.80M | 22.71M | |
|
|
|||||
| Total Current Assets | 98.17M | 113.00M | 23.80M | 22.71M | |
| Net Property, Plant & Equipment | 1.60M | 1.80M | 1.63M | 1.77M | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 109.00K | 109.00K | 49.00K | 51.00K | |
| Total Assets | 99.88M | 114.91M | 25.47M | 24.53M | |
|
|
|||||
| Total Accounts Payable | 2.34M | 2.97M | 8.26M | 3.62M | |
| Total Accrued Expenses | 5.90M | 7.03M | 4.51M | 1.72M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 546.00K | 536.00K | 216.00K | 212.00K | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 8.79M | 10.53M | 12.98M | 5.55M | |
|
|
|||||
| Total Current Liabilities | 8.79M | 10.53M | 12.98M | 5.55M | |
| Long-Term Debt | -- | -- | 5.86M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 409.00K | 549.00K | 357.00K | 412.00K | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 40.00K | -- | 26.00K | -- | |
| Total Liabilities | 9.23M | 11.08M | 19.23M | 5.96M | |
|
|
|||||
| Common Stock & APIC | 261.30M | 258.55M | 2.15M | 326.00K | |
| Retained Earnings | -170.65M | -154.72M | -125.73M | -111.59M | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 90.65M | 103.83M | -123.58M | -111.26M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | 129.83M | 129.83M | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | 129.83M | 129.83M | |
|
|
|||||
| Total Common Equity | 90.65M | 103.83M | -123.58M | -111.26M | |
| Total Preferred Equity | -- | -- | 129.83M | 129.83M | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 90.65M | 103.83M | 6.25M | 18.56M | |
|
|
|||||